In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B round for device maker Pulmonx grosses $20mm

Executive Summary

Pulmonx (developing a minimally invasive intrabronchial valve that reduces lung volume) raised $20mm in a Series B financing led by first-time backer De Novo Ventures, which was joined by fellow new investor Latterell Venture Partners and returning shareholders Montreux Equity Partners and MedVenture Associates.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies